Newsfiscal.ai
Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Results
· Published
Article summary
Agenus Inc. announced the peer-reviewed publication of results from the Phase 2 UNICORN trial, which evaluated neoadjuvant botensilimab and balstilimab in patients with resectable colon cancer.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…